2015
DOI: 10.1016/j.it.2015.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Exit Strategies: S1P Signaling and T Cell Migration

Abstract: Whereas the role of sphingosine 1-phosphate receptor 1 (S1PR1) in T cell egress and the regulation of S1P gradients between lymphoid organs and circulatory fluids in homeostasis are increasingly well-understood, much remains to be learned about S1P signaling and distribution during an immune response. Recent data suggest that the role of S1PR1 in directing cells from tissues into circulatory fluids is reprised again and again, particularly in guiding activated T cells from non-lymphoid tissues into lymphatics.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
102
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 134 publications
(102 citation statements)
references
References 91 publications
0
102
0
Order By: Relevance
“…LCL351 elevated circulating S1P levels basally; however, this was not significant and LCL351 prevented DSS-induced increases in S1P (Table S1). While we know that the S1P gradient is important for egress of WBCs from secondary lymph tissues and other vascular and immunological biologies (reviewed in [41]), we know relatively little about the role of S1P in WBC infiltration into inflamed tissues [42]. However, we hypothesize that the number of circulating WBCs are increased in response to LCL351, partly due to the inability of LCL351 to inhibit SK1 in circulation (half-life 30–45 minutes; slight basal increase in S1P).…”
Section: Discussionmentioning
confidence: 99%
“…LCL351 elevated circulating S1P levels basally; however, this was not significant and LCL351 prevented DSS-induced increases in S1P (Table S1). While we know that the S1P gradient is important for egress of WBCs from secondary lymph tissues and other vascular and immunological biologies (reviewed in [41]), we know relatively little about the role of S1P in WBC infiltration into inflamed tissues [42]. However, we hypothesize that the number of circulating WBCs are increased in response to LCL351, partly due to the inability of LCL351 to inhibit SK1 in circulation (half-life 30–45 minutes; slight basal increase in S1P).…”
Section: Discussionmentioning
confidence: 99%
“…Researchers have recently investigated strategies to target the sphingosine-1-phosphate pathway, which reduces circulating lymphocytes by sequestering them in secondary lymphoid organs. 127 In a phase 2 trial of patients with UC, once daily ozanimod (1 mg) resulted in statistically significant increases in clinical remission and mucosal healing at week 8 compared with placebo. 128 An important observation from this trial was that the rates of histologic remission (22%) were lower than the rates of mucosal healing at week 8 (34%) with ozanimod, but by week 32 these rates were more comparable (31% vs 33%).…”
Section: Inhibiting Additional Cytokine Pathwaysmentioning
confidence: 99%
“…CD8-Trm remain in tissues despite the lack of persistent antigen6, an attribute associated with the expression of CD69 and CD10378. CD69, the classical early activation marker, also has a reciprocal relationship with sphingosine-1-phosphate receptor-1 (S1PR1)9; CD69 upregulation leads to S1PR1 downregulation, which prevents cell egress from both lymphoid and non-lymphoid organs following sphingosine-1-phosphate (S1P) gradients1011. CD103 is the ligand for e-cadherin12, which is highly expressed on epithelial cells in mucosal tissues13.…”
mentioning
confidence: 99%